BOC and CryoCath launch new technology to fight heart disease in Europe

A partnership between BOC and a Canadian company will see groundbreaking medical technology used to cure cardiovascular disease being made available throughout Europe.The technology, which uses freezing temperatures to treat diseased tissue of patients with irregular heartbeats, has been developed by Montreal-based CryoCath Technologies, and has been successfully launched in ...

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content from just $250 per annum, or if you are only interested in North American content, pay just $190!